Korio, Inc., the pioneering Randomization & Trial Supply Management (RTSM) technology company, today announced the successful completion of its Series A funding round led by BIP Ventures, with participation from existing investors Excelerate Health Ventures, Boston Millennia Partners, and other strategic investors.
Catalera BioSolutions (“Catalera”), a pioneering innovator in biological pest control solutions, today announced the initial close of its Series A funding round. Launched mid-May, Catalera is an independent company spun out from Terramera, an ag-tech company based in Vancouver.
CSA Medical, developer of The RejuvenAir® System, announced oversubscribed $53 million Series D preferred stock equity financing. This round will fund the company though expected U.S. Food and Drug Association (FDA) premarket approval (PMA) and the building of a comprehensive commercialization strategy for successful U.S. launch.
Superluminal Medicines, Inc., “The Membrane Company” using generative biology, chemistry, and machine learning approaches to revolutionize the speed and accuracy of how medicines are created, today announced the closing of a $120 million Series A funding round.
Sedric AI, the pioneering compliance-dedicated AI platform for financial institutions, today announced it has closed a $18.5 million Series A funding round to further its efforts to transform compliance operations across the industry.
MA-based Mantel Capture, the technology provider of a carbon capture system using molten borates, has raised $30 million in Series A funding round co-led by Shell Ventures and Eni Next. Additional participating investors include Engine Ventures, New Climate Ventures, Hartree, bp Ventures, Arosa Ventures, Vale Ventures, Newlab, MCJ Collective, and others.
Revefi has raised $20 million in a Series A financing. The new funds will fuel the launch of Raden -- the world's first AI data engineer. Raden uses the power of GenAI + AI to augment busy data teams and vastly improve organizations’ ROI from their data investments. The new round was led by Icon Ventures, with participation from Mayfield, GTM Capital and StepStone Group.
CA-based Cortex, the Internal Developer Portal eliminating “developer tax” with paved paths to production has raised $60 million in series C funding round, led by Scale Venture Partners, with participation from World Innovation Labs, Cross Creek, Alpha Square Group, Patrick and John Collison (Stripe) IVP, Sequoia, and Y Combinator.
eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the close of a $191 million Series D financing. Proceeds will be used to advance the company’s lead product candidate, EGEN-2784, to a first-in-human study for kidney transplant. The funding will also be used to advance pipeline programs as well as scale production.
Ceres, an AI and data analytics platform to acquire, manage, and insure farmlands has raised series D funding led by Remus Capital. Ceres also rebrand to Ceres AI highlights a foundation and leadership in computer vision and machine learning, which are crucial in enabling all participants in the agricultural industry - in particular large agribusinesses and financial services customers - to access quality data to make faster and more accurate data-driven decisions.
